Exelixis, Inc. (NASDAQ:EXEL) Insiders Have Been Selling

It is not uncommon to see companies perform well in the years after insiders buy shares. On the other hand, we'd be remiss not to mention that insider sales have been known to precede tough periods for a business. So shareholders might well want to know whether insiders have been buying or selling shares in Exelixis, Inc. (NASDAQ:EXEL).

Advertisement

What Is Insider Buying?

It is perfectly legal for company insiders, including board members, to buy and sell stock in a company. However, such insiders must disclose their trading activities, and not trade on inside information.

We would never suggest that investors should base their decisions solely on what the directors of a company have been doing. But logic dictates you should pay some attention to whether insiders are buying or selling shares. As Peter Lynch said, 'insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise.'

Check out our latest analysis for Exelixis

Exelixis Insider Transactions Over The Last Year

The Independent Director, Charles Cohen, made the biggest insider sale in the last 12 months. That single transaction was for US$5.5m worth of shares at a price of US$22.41 each. That means that an insider was selling shares at around the current price of US$19.79. We generally don't like to see insider selling, but the lower the sale price, the more it concerns us. In this case, the big sale took place at around the current price, so it's not too bad (but it's still not a positive).

In the last twelve months insiders netted US$8.6m for 410k shares sold. In the last year Exelixis insiders didn't buy any company stock. The chart below shows insider transactions (by individuals) over the last year. If you want to know exactly who sold, for how much, and when, simply click on the graph below!

NasdaqGS:EXEL Recent Insider Trading, August 5th 2019
NasdaqGS:EXEL Recent Insider Trading, August 5th 2019

Exelixis Insiders Are Selling The Stock

The last quarter saw substantial insider selling of Exelixis shares. In total, Independent Director Lance Willsey sold US$1.0m worth of shares in that time, and we didn't record any purchases whatsoever. In light of this it's hard to argue that all the insiders think that the shares are a bargain.

Insider Ownership of Exelixis

For a common shareholder, it is worth checking how many shares are held by company insiders. We usually like to see fairly high levels of insider ownership. Insiders own 1.3% of Exelixis shares, worth about US$78m. This level of insider ownership is good but just short of being particularly stand-out. It certainly does suggest a reasonable degree of alignment.

What Might The Insider Transactions At Exelixis Tell Us?

An insider sold Exelixis shares recently, but they didn't buy any. And there weren't any purchases to give us comfort, over the last year. On the plus side, Exelixis makes money, and is growing profits. Insiders own shares, but we're still pretty cautious, given the history of sales. We'd think twice before buying! If you are like me, you may want to think about whether this company will grow or shrink. Luckily, you can check this free report showing analyst forecasts for its future.

If you would prefer to check out another company -- one with potentially superior financials -- then do not miss this free list of interesting companies, that have HIGH return on equity and low debt.

For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.

We aim to bring you long-term focused research analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.

If you spot an error that warrants correction, please contact the editor at editorial-team@simplywallst.com. This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Simply Wall St has no position in the stocks mentioned. Thank you for reading.

MI
mitchell_lawler
mitchell_lawler

Apple's near record highs, yet the AI crowd still writes it off as a laggard. I think they're misreading the strategy.

Apple's near record highs, yet the AI crowd still writes it off as a laggard. I think they're misreading the strategy. cover
1210
AR
artoflosing
artoflosing

Apple now is a hedge for hyperscalers.

JA
Jake_Merritt
Jake_Merritt

In that case Google is better placed. It owns both the model and the massive distribution.

Mitchell Lawler

Which payment stocks actually get paid?

Which payment stocks actually get paid? cover
Every new payment app was supposed to kill Visa and Mastercard. Instead, they got bigger. So what does that mean for the payment stocks on your radar?
32

About NasdaqGS:EXEL

Exelixis

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

Flawless balance sheet and undervalued.

Advertisement

Weekly Picks

RI
Rick_Orford
FJET logo
Rick_Orford on Starfighters Space ·

The 1960s Fighter Jet That Could Crack Open a $20 Billion Satellite Market

Fair Value:US$522.0% undervalued
63 users have followed this narrative
4 users have commented on this narrative
11 users have liked this narrative
JO
John_Eric
MELI logo
John_Eric on MercadoLibre ·

MercadoLibre and the Spreadsheet Trick That Decides Everything

Fair Value:US$7.31k73.7% undervalued
116 users have followed this narrative
3 users have commented on this narrative
17 users have liked this narrative
RC
PYPL logo
rcb9 on PayPal Holdings ·

Ten Percent More Volume, One Percent More Transaction Margin

Fair Value:US$70.8913.2% undervalued
18 users have followed this narrative
1 users have commented on this narrative
6 users have liked this narrative
HE
HedgeY
MU logo
HedgeY on Micron Technology ·

Micron - The Memory Bottleneck Behind the AI Supercycle

Fair Value:US$1.25k22.7% undervalued
48 users have followed this narrative
0 users have commented on this narrative
17 users have liked this narrative

Updated Narratives

BA
RHM logo
Baranclever on Rheinmetall ·

Rheinmetall AG: 2029 Valuation Outlook — €2,900–€6,800 per Share

Fair Value:€5.87k80.8% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
BE
ALV logo
Beastor on Alvopetro Energy ·

Alvopetro Energy - Good Dividend but limited upside potential at price around $10

Fair Value:CA$10.151.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
TR
TripleS
HHS logo
TripleS on Harte Hanks ·

Star Equity (STRR) is buying Harte-Hanks (HHS) at $5.00 a share, half in cash and half in a 10% cumulative preferred (STRRP). HHS trades at

Fair Value:US$4.9525.7% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28023.3% undervalued
345 users have followed this narrative
9 users have commented on this narrative
16 users have liked this narrative
CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.9115.1% overvalued
194 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative
KI
AMZN logo
KiwiInvest on Amazon.com ·

Amazon's high growth, high tech segments propel its profits, while traditional segments plod along

Fair Value:US$475.0945.6% undervalued
222 users have followed this narrative
1 users have commented on this narrative
8 users have liked this narrative

Trending Discussion

HA
HarishPK
EVER logo
HarishPK on EverQuote ·

Feedback welcome!

3
|
0
MA
MRNA logo
Madave on Moderna ·

Aged like wine

2
|
0